World High Life Plc (AQSE:LIFE)(OTCQB:WRHLF) announces that World High Life wholly owned subsidiary, Love Hemp, has developed and launched a new brand to market, Buzz Leaf, which is targeted to a younger demographic (ages 21-34) in order to grow market share.
Love Hemp’s new product development strategy is central to the company’s growth plan, building on the strength of the Love Hemp branded product range, the focus is to develop brands to engage new consumers, increasing overall market share.
Buzz Leaf products have been developed and designed to connect with a younger demographic, giving the brand more freedom on the types of product categories it includes, from vapes to full spectrum CBD oils and enhancement products, for example benefit led products such as a hangover remedy, and cognition and libido enhancers.
The new Buzz Leaf CBD range of products includes the release of four broad spectrum CBD infused e-liquids with added terpenes and will be available exclusively at www.cbdoilsuk.com.
The e-liquids feature exotic flavours including Horny Mango & Pineapple Express, Blue Mist & Blue Dream, Tigers Blood & Watermelon OG and Lykos & Grandaddy Purple. The CBD infused e-liquids are priced at £24.99 for 30ml and contain 500mg of CBD.
Whilst all flavours are expected to be popular with both new and existing CBD vapers, clear winners are Horny Mango & Pineapple Express as well as Blue Mist & Blue Dream. The e-liquids are a welcome new addition to the CBDOilsUK range of products, appealing to a diverse audience, whilst building on the already successful range of Love Hemp e-liquids the online retailer stocks.
“With consumers demanding more high quality products at reasonable prices, our goal is to not only deliver strong margins for Buzz Leaf, but also provide competitively priced, high quality product options for a wider range of consumers – we really want to have something for everyone,” says Tony Calamita, CEO at Love Hemp.
In addition to the launch of the four broad spectrum CBD infused e-liquids with added terpenes, Buzz Leaf is planning to launch a full range of CBD products including capsules and oils. For further information on Buzz Leaf, visit www.cbdoilsuk.com.
The Directors of the Company accept responsibility for the contents of this announcement.
For further information please contact:
Founder & CEO
North America: 1 (236) 521-7211
North America toll-free: 1 (888) 616-WRHLF (9745)
+44 (0) 7926 397 675
AQSE Corporate Adviser
Mark Anwyl/Allie Feuerlein
Peterhouse Capital Limited
+44 (0) 20 7469 0930
Camilla Horsfall/Megan Ray
+44 (0) 20 7138 3224
Market Abuse Regulation (MAR) Disclosure
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
Cautionary Note Regarding Forward Looking Information
We seek safe harbour. Some statements contained in this news release are “forward looking information” within the meaning of securities laws. Forward looking information include, but are not limited to, statements regarding the use of proceeds of the non-brokered private placement and payment of the debt settlements. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, “believes” or variations of such words and phrases (including negative or grammatical variations) or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” or the negative connotation thereof. Investors are cautioned that forward-looking information is inherently uncertain and involves risks, assumptions and uncertainties that could cause actual results to differ materially. There can be no assurance that future developments affecting the Company will be those anticipated by management. The forward-looking information contained in this press release constitutes management’s current estimates, as of the date of this press release, with respect to the matters covered thereby. We expect that these estimates will change as new information is received. We do not undertake to update any estimate at any particular time or in response to any particular event, except as required by law.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact firstname.lastname@example.org or visit www.rns.com.
SOURCE: World High Life Plc
View source version on accesswire.com:
Love Hemp Group PLC
In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.
Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.
The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement
Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination
Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces that as part of the equity fundraise announced yesterday, Antony Calamita and Andrew Male, Directors of the Company, subscribed for 285,714 Ordinary Shares and 1,428,571 Ordinary Shares respectively. The subscriptions are at a price of 3.5 pence per ordinary share for a total of £60,000. Following these subscriptions, Antony Calamita is now interested in 54,385,714 Ordinary Shares, representing 8.61% of the Company’s share capital as increased by the fundraising, and Andrew Male is now interested in 6,138,196 Ordinary Shares, representing 0.97% of the Company’s issued share capital as increased by the fundraising
Further, the timetable for receipt of applications under the Broker Option, which was also announced yesterday, has been extended until 5:00 pm 9 April 2021 to capture additional interest which was unable to be completed yesterday.
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign.
In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the Meeting via teleconference and will not be permitted to attend the Meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders.
Gage Cannabis Announces Exclusive Partnership With Blue River to Bring Award-Winning Cannabis Extracts to Michigan
Gage Growth Corp. (“Gage” or the “Company”) (CSE:GAGE), a leading high-quality craft cannabis brand and operator in Michigan, announced today that it has signed an agreement with Blue River™ Extracts & Terpenes (“Blue River™”) to bring the brand’s award-winning solventless technology and other trademark branded products to the state’s medical patients and cannabis consumers. The Company will have exclusive rights to Blue River™’s premium product offerings in Michigan.